Joel Habener is a professor of medicine atHarvard Medical School and an associate physician at theMassachusetts General Hospital.^[1]

Habener graduated with a BS degree Cum Laude from the University of Redlands in 1960. He received his MD in 1965 from the University of California School of Medicine.^[2]

Habener worked withSvetlana Mojsov on elucidating the role ofincretinhormones such asglucagon-like peptide-1 (GLP-1) andglucagon-like peptide-2 (GLP-2).^[3]

Habener was awarded the 2020Warren Alpert Foundation Prize along withDaniel Drucker andJens Juul Holst.^[4] He was elected to theNational Academy of Sciences in 2020.^[5] In 2021, he was awarded theCanada Gairdner International Award.^[6] In 2023, he received theVinFuture Prize.^[7] In 2024, he was awarded thePrincess of Asturias Awards for Technical and Scientific Research,^[8] theTang Prize in the category of "Biopharmaceutical Science",^[9] theLasker Award for clinical research^[10][11] and theBBVA Foundation Frontiers of Knowledge Award in the category "Biology and Biomedicine".^[12] In 2025 he received theBreakthrough Prize in Life Sciences.^[13]

This biographical article related to a physician in the United States is astub. You can help Wikipedia byexpanding it.

• v
• t
• e

• Harvard Medical School staff
• Medical researchers
• Members of the United States National Academy of Sciences
• Living people
• American physician stubs

• Articles with short description
• Short description matches Wikidata
• Articles with hCards
• Year of birth missing (living people)
• All stub articles